The antitumor activity of an anti-CD22 immunotoxin in SCID mice with disseminated Daudi lymphoma is enhanced by either an anti-CD19 antibody or an anti-CD19 immunotoxin

Medicine & Life Sciences

• Immunotoxins 85%
• SCID Mice 75%
• Anti-Idiotypic Antibodies 53%
• Lymphoma 53%
• Antibodies 28%
• Paralysis 24%
• Ricin 18%
• Neoplasms 16%
• Paraplegia 14%
• Intravenous Injections 12%
• Inhibitory Concentration 50 11%
• Spine 9%
• Monoclonal Antibodies 9%
• In Vitro Techniques 5%
• Therapeutics 2%

Chemical Compounds

• Immunotoxin 100%
• Antitumor 58%
• Ricin 22%
• Mixture 20%
• Time 11%
• Column Like Crystal 9%